Welcome to Seacross Pharmaceuticals Ltd.
Products
Oncology Injectable Other Product 1 Other Product 2
Zoledronic acid Seacross 5 mg/100 ml

Therapeutic indications:  

---4mg/100ml and 4mg/5ml:

• Prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone.

• Treatment of adult patients with tumour-induced hypercalcaemia (TIH).


---5mg/100ml:
 *Treatment of osteoporosis
   • in post-menopausal women
   • in adult men 
   at increased risk of fracture, including those with a recent low-trauma hip fracture.
 *Treatment of osteoporosis associated with long-term systemic glucocorticoid therapy
   • in post-menopausal women
   • in adult men 
   at increased risk of fracture.
 *Treatment of Paget’s disease of the bone in adults.

Form Concentrate for solution for infusion
Strength 5mg/100ml, 4mg/100ml, 4mg/ 5ml
Active substance Zoledronic acid
Other ingredients Mannitol(421), sodium citrate, water for injections
© Copyright - Clinico fusce blandit sapien eu